678 related articles for article (PubMed ID: 19580856)
1. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
[TBL] [Abstract][Full Text] [Related]
2. Wheat germ agglutinin-functionalised crosslinked polyelectrolyte microparticles for local colon delivery of 5-FU: in vitro efficacy and in vivo gastrointestinal distribution.
Glavas-Dodov M; Steffansen B; Crcarevska MS; Geskovski N; Dimchevska S; Kuzmanovska S; Goracinova K
J Microencapsul; 2013; 30(7):643-56. PubMed ID: 23544879
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
4. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
Simonoska Crcarevska M; Glavas Dodov M; Goracinova K
Eur J Pharm Biopharm; 2008 Mar; 68(3):565-78. PubMed ID: 17651952
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
6. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
Yan C; Chen D; Gu J; Qin J
J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
[TBL] [Abstract][Full Text] [Related]
9. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads.
Pasparakis G; Bouropoulos N
Int J Pharm; 2006 Oct; 323(1-2):34-42. PubMed ID: 16828245
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
11. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.
Lin YH; Liang HF; Chung CK; Chen MC; Sung HW
Biomaterials; 2005 May; 26(14):2105-13. PubMed ID: 15576185
[TBL] [Abstract][Full Text] [Related]
12. Triggering effect of N-acetylglucosamine on retarded drug release from a lectin-anchored chitosan nanoparticles-in-microparticles system.
Li H; Dong WF; Zhou JY; Xu XM; Li FQ
Int J Pharm; 2013 Jun; 449(1-2):37-43. PubMed ID: 23587965
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.
Mo Y; Lim LY
J Control Release; 2005 Sep; 107(1):30-42. PubMed ID: 16051391
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
Agnihotri SA; Aminabhavi TM
J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
[TBL] [Abstract][Full Text] [Related]
15. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
16. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
17. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
18. Alginate microparticles prepared by spray-coagulation method: preparation, drug loading and release characterization.
Tu J; Bolla S; Barr J; Miedema J; Li X; Jasti B
Int J Pharm; 2005 Oct; 303(1-2):171-81. PubMed ID: 16129575
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies.
Yu X; Pishko MV
Biomacromolecules; 2011 Sep; 12(9):3205-12. PubMed ID: 21786828
[TBL] [Abstract][Full Text] [Related]
20. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
